1-4 of 4
Maurice Genereux, MD
Close
Sort by
Journal Articles

Potential Identification of High Risk Populations for Acute Hemolytic Reactions Following Rh 0 (D) Immune Globulin.

Paraneedharan Ramachandran, MD, Daniel Li, MSc, Carmen Muller, MD, Gregg Little, RPh, Chris Sinclair, PhD, MBA, Maurice Genereux, MD
Journal: Blood
Blood (2010) 116 (21): 3685.
https://doi.org/10.1182/blood.V116.21.3685.3685
Published: 2010
Journal Articles

Which Hematological Malignancies Are Implicated In Acute Hemolytic Reactions Following Rh (D) Immune Globulin for ITP

Hugo Astacio, MD, Carmen Muller, MD, Gregg Little, RPh, Chris Sinclair, PhD, MBA, Maurice Genereux, MD
Journal: Blood
Blood (2010) 116 (21): 4670.
https://doi.org/10.1182/blood.V116.21.4670.4670
Published: 2010
Journal Articles

Are Communication Tools Effective in Increasing Reporting Rate of Acute Hemolytic Reactions (AHR) In ITP Patients Treated with Rh (D) Immune Globulin?

Faiz Guirgis, MD, Carmen Muller, MD, Gregg Little, RPh, Chris Sinclair, PhD, MBA, Maurice Genereux, MD
Journal: Blood
Blood (2010) 116 (21): 4677.
https://doi.org/10.1182/blood.V116.21.4677.4677
Published: 2010
Journal Articles

Equivalence of Liquid and Freeze-Dried Formulations of WinRho® SDF.

Christopher J. Sinclair, PhD, Jon Ruckle, MD, Dennis Swearingen, MD, James C. Kisicki, MD, Thomas C. Marbury, MD, Maurice Genereux, MD, William Brooks, PhD
Journal: Blood
Blood (2005) 106 (11): 3988.
https://doi.org/10.1182/blood.V106.11.3988.3988
Published: 2005